Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply

Volume: 59, Issue: 9, Pages: e48 - e49
Published: Jun 28, 2020
Abstract
No abstract.
Paper Details
Title
Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply
Published Date
Jun 28, 2020
Volume
59
Issue
9
Pages
e48 - e49
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.